CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...
Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the ...
Voxela, Inc. (Voxela), which created the AI care management system Voxela VCare, has completed its pre-Series A funding round. The company's proven track record of deployments in Japanese care ...
This milestone... at 13:00 Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia GSK announced today that Health Canada has approved ...
Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the secon ...
† Those without notes are either nonspecific or give too many clues of the diseases that cannot be listed. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; FDG PET-CT ...